Uniphar plc

11/19/2026 | Press release | Distributed by Public on 11/19/2026 01:34

Directorate change


Uniphar plc

Directorate Changes

Dublin, London | 19 November 2026: Uniphar plc (the "Company" or "Uniphar"), an international diversified healthcare services business, is pleased to announce that the Board has approved the appointment of Roger Gillespie to its Board as an independent non-executive Director, with effect from 25 January 2027.

A Chartered Accountant, Roger has extensive experience in professional advisory services and board-level governance and leadership. In a career with KPMG stretching over four decades, Roger worked closely with some of Ireland's largest publicly listed and private companies, in the role of Audit Partner and Deal Advisory Partner, serving clients in the healthcare, industrial, retail and agri food sectors.

Since retiring from KPMG in 2024, Roger has provided consultancy services and holds a number of non-executive board roles, including in the healthcare sector. Roger brings a detailed understanding of financial reporting, corporate governance, equity capital and debt markets and mergers and acquisitions.

Other Board Changes

Further to previous statements, the Board also announces that Maurice Pratt stepped down as Chair of the Company, and Paul Hogan took over the role of Chair, on 18 November 2026. Maurice will remain on the Board as a Director until 6 May 2027. Sue Webb also assumed the role of Senior Independent Director, replacing Paul Hogan, on 18 November 2026.

Ger Rabbette, Chief Executive Officer of Uniphar, commented:

"Maurice has served on the Uniphar Board for over 20 years, including as Chair for 17 years. In that time, Maurice has made an unparalleled contribution to Uniphar, guiding the company in the worst of times and the best of times. He saw Uniphar through the difficulties following the financial crisis of 2008, the acquisition of CMR, the recovery of the business and the expansion beyond Ireland into Europe, the US and beyond and, of course, to flotation in 2019.

Clear-headed and strategic, he always worked closely with his Board to provide the executive team with an ideal combination of challenge, sage advice and support.

An accomplished business leader, ambitious for the company and open to the ideas of others, Maurice has been more than instrumental in creating the environment which allows the Board and the business to believe that our greatest aspirations can be achieved. Both as a colleague and a friend, he will be sorely missed."

--- ENDS ---

Contact details

Uniphar Group

Tel: +353 (0) 1 428 7777

Allan Smylie, Head of Strategy and IR

Davy (Joint Corporate Broker, Nominated Advisor and

Euronext Growth Listing Sponsor)

Tel: +353 (0) 1 679 6363

Daragh O'Reilly

Niall Gilchrist

Ivan Murphy

RBC Capital Markets (Joint Corporate Broker)

Tel: +44 (0) 20 7653 4000

Jamil Miah

Daniel Saveski

Stifel Nicolaus Europe Limited (Joint Corporate Broker)

Tel: +44 (0) 20 7710 7600

Matt Blawat

Ben Maddison

Francis North

Q4 PR

Tel: +353 (0) 1 475 1444

Iarla Mongey, Public Relations Advisor to Uniphar Group

About Uniphar plc

Headquartered in Dublin, Ireland, the Uniphar Group is an international diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. The Group is active in Europe, North America, APAC and MENA and delivers to 160+ countries.

The Company's vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare stakeholders. Uniphar represents a strong combination of scale, growth, and profitability.

Uniphar Supply Chain & Retail

Uniphar Supply Chain & Retail is the leading pharmaceutical wholesaler in Ireland with a growing symbol group offering of retail pharmacies. The Group's strategy for Uniphar Supply Chain & Retail is to grow our wholesale market share, our symbol group network and our own brand, in-licenced and consumer products portfolio.

Uniphar Medtech

Uniphar Medtech is a leading Pan-European medical device distributor and solutions partner. The Group's strategy for Uniphar Medtech is to grow our service offering across Europe and expand our addressable market by serving new specialities and new manufacturers.

Uniphar Pharma

Uniphar Pharma operates a global business with high value services across the lifecycle of a pharmaceutical product. We enable pharma and biotech companies to bring innovative medicines to global markets and provide healthcare professionals with access to medicines they can't source through traditional channels. Our strategy is to build a leading platform to provide the specialist support and expertise needed to improve access to these medicines.

Uniphar plc published this content on November 19, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 19, 2026 at 07:34 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]